Japan’s Ministry of Health, Labor and Welfare in Japan has granted marketing and manufacturing authorization for Dupixent ...

The European Medicines Agency will review GSK's request to approve its asthma drug Nucala as an additional treatment for ...

Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils ...

You have full access to this article via your institution. Available treatments for COPD are mainly palliative, and there are no therapies available that halt the decline in lung function or the ...

Whether finding new treatments for schizophrenia or first-time ways to tackle bladder cancer, these companies are finding ...

The Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing authorization for Dupixent (dupilumab) for the treatment of chronic obstructive pulmonary disease (COPD) in ...

In September, Bristol Myers Squibb got the agency’s greenlight for Cobenfy, the first major new drug for ... treatment for COPD offers a breakthrough in maintenance therapy that will help ...

Paris and Tarrytown, NY, March 28, 2025. The Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing authorization for Dupixent (dupilumab) for the treatment of chronic ...

China: A recent multicenter randomized controlled trial has highlighted the potential benefits of acupuncture as a ...

Bristol Myers Squibb will acquire 2seventy bio for about $286 million in cash, sending the cancer cell therapy maker's shares ...

Cost-saving techniques include using sliding scale providers, group therapy, and drug discount cards. Management of bipolar disorder often involves a combination of various approaches, such as ...